Aesthetic & Cosmetic Equipment Financing:
Lasers, Body Contouring, RF and More.

iLease Capital finances new, used and refurbished aesthetic and cosmetic equipment, from laser and IPL platforms to body-contouring systems, RF microneedling devices and skin-resurfacing lasers. Aesthetics is one of the most distinctive categories in medical equipment finance, because the technology moves on short cycles, the used market is unusually active and the device is often bought to generate revenue per treatment rather than to support an existing service line. That combination changes how the equipment should be valued and financed. If you are pricing an aesthetic device, new or used, you can talk it through with a specialist at (866) 545-3273.

iLease Capital finances aesthetic equipment for med-spas, dermatology and plastic surgery practices, cosmetic clinics and multi-specialty groups and financing may be available for transactions up to $5 million plus with no minimum floor. As a broker with more than 50 lender relationships rather than a single direct lender, iLease can match a specific device to a funding partner that understands the secondary market for aesthetic collateral, which matters because a lender who prices a two-year-old laser platform off its original invoice will misjudge both the value and the payment. This guide breaks the category down by device type, with current market price ranges, the active used market, the depreciation curve and why revenue per treatment sits at the center of the underwriting. For the broader clinical picture, see our medical equipment financing hub.

Aesthetic Laser Platforms

Laser platforms are the backbone of most aesthetic practices and they cover a wide price band. A general platform handling hair removal, vascular lesions and light resurfacing commonly runs $45,000 to $150,000 new, moving up as the system adds wavelengths and interchangeable handpieces, while the refurbished market runs from roughly $8,000 for an older single-wavelength unit to well over $100,000 for a recent multi-handpiece platform. Alexandrite and Nd:YAG hair and vascular systems in the popular workhorse class commonly run in the mid five figures to low six figures new, with refurbished units frequently available in the high five figures. The main financing nuance is that a superseded platform can lose value quickly once a newer generation ships, so the model year, the handpiece set and remaining lamp or tube life define what a specific unit is worth far more than the model name alone.

Picosecond and Pigment Lasers

Picosecond lasers used for tattoo removal, pigment correction and resurfacing sit at the higher end of the laser range, with new systems often running into six figures depending on the configuration. This is also a category where the used market spread is dramatic, because a current-generation picosecond platform holds value while a superseded model can trade for a small fraction of its original price. That gap is the clearest illustration of why aesthetic collateral needs equipment-specific valuation rather than a generic medical depreciation schedule and it is why the model year and the software or wavelength options carry so much weight on a used unit. For a practice weighing a used picosecond system, the upside is real, because a one-generation-back platform can deliver the same core treatments at a materially lower entry cost and the resale strength of the treatments it performs often holds up even when the hardware has been superseded. The financing simply needs to be sized against what that specific unit is worth today, which is where a funding partner who follows the category earns its place.

IPL and Photorejuvenation Systems

Intense pulsed light systems are the most accessible entry point into energy-based aesthetics. Standalone IPL and photorejuvenation systems commonly run $20,000 to $60,000 new, with an active refurbished market where basic units are available from a few thousand dollars up into the mid five figures. Because the entry price is modest and the resale market is liquid, IPL is often a straightforward transaction and smaller units may qualify for application-only financing. As with any lamp-based device, the condition and expected life of the lamp, along with any consumable tips or filters, factor into how the unit is valued.

Body Contouring Systems

Body contouring is one of the fastest-growing revenue lines in aesthetics and the equipment reflects it. High-intensity electromagnetic and RF muscle-building systems commonly run $90,000 to $175,000 new, with an active refurbished market where units frequently trade in the high five figures to low six figures. Cryolipolysis fat-reduction systems commonly run roughly $100,000 to $200,000 new, with refurbished units available for less, though these devices often carry per-cycle applicator fees that tie the asset to an ongoing manufacturer cost. Pelvic-floor strengthening chairs using the same electromagnetic technology sell across a wide band new, with a broad used market. Across all of these, the recurring theme for financing is that consumables and per-treatment fees entangle the device with an ongoing payment stream, so it helps to lay out what transfers with a used unit and what the ongoing costs are.

RF Microneedling Devices

Radiofrequency microneedling has become a core offering in med-spas and dermatology practices and it spans a clear price ladder. Premium channel-controlled systems commonly run $90,000 to $120,000 new and notably they hold value well on the used market, often trading in the $70,000 to $90,000 range. Mid-tier systems commonly run $60,000 to $90,000 new, with refurbished units roughly $30,000 to $55,000, while entry-level devices run about $35,000 to $55,000 new and are available used from the mid teens. RF microneedling is a useful example of how much the specific platform matters, because a premium device that controls disposable tips through a licensed cartridge behaves differently as collateral than a lower-cost open system and both the tip cost and the resale strength feed into the financing.

Ablative Resurfacing and CO2 Lasers

Ablative and fractional resurfacing lasers, including CO2 and modular systems that combine broadband light with resurfacing and fractional non-ablative modes, sit toward the upper end of the aesthetic range. Modular platforms that bundle several treatment modes commonly run $80,000 to $120,000 or more new, with a healthy refurbished market where units trade in the mid five figures to low six figures. These systems are attractive because a single platform can deliver multiple billable treatments, which strengthens the revenue case and that same versatility tends to support resale value. As with other laser devices, the generation, the installed modules or handpieces and remaining tube life are what define the value of a used unit.

Med-Spa Support and Ancillary Devices

Beyond the headline energy-based platforms, most aesthetic and cosmetic practices build out a supporting layer of equipment that is just as financeable. Injectable-focused practices add treatment chairs and stools, exam and procedure lighting, refrigeration for product storage and point-of-care support equipment, while med-spas commonly add hydradermabrasion and facial systems, LED phototherapy panels, cooling and skin-analysis devices and the furniture and reception build-out that a patient-facing practice needs. These items are lower in cost individually and they are frequently rolled into the same financing as the primary device so the practice can open or expand with one structure rather than a series of separate purchases. Because many of these ancillary purchases are modest in size, they are natural candidates for a short application and packaging them with the main platform keeps the whole build-out on a single monthly payment.

The Unusually Active Used Market

Aesthetic devices trade on one of the most active secondary markets in all of equipment finance and that fact shapes every deal in the category. On one hand, an active used market gives a lender real comparable sales to value the collateral against, which is useful. On the other hand, aesthetic equipment is mobile and easy to consign or resell, which raises recovery potential but also means a device can be moved or sold quickly, so lenders weigh both sides. The practical takeaway for a practice is that the resale market sets the true value of the asset, not the list price and a funding partner who follows that market will size the payment more accurately. Presenting a used device with its model year, handpieces, service records and any transferable warranty gives the lender what it needs to value the unit against real comps. It is also worth noting that manufacturers in this category tend to keep list pricing off the public record and quote each buyer individually, so an underwriter often works from broker comparables rather than a published price sheet. That is another reason a specialist who tracks the aesthetic secondary market can move faster on a valuation, because the reference points come from actual transactions rather than a sticker that may never have reflected what anyone paid.

Short Technology Cycles and Fast Depreciation

Aesthetic technology moves on short cycles and the depreciation can be brutal to resale value. When a manufacturer ships a new generation, the prior model often craters in the secondary market, so a device that commanded six figures new can sell for a small fraction of that once it is superseded. This is exactly why a generic medical depreciation schedule does not fit aesthetic collateral and why the category rewards a lender who prices equipment-specific depreciation into the structure. For a practice, the lesson is twofold: buying near the top of a technology cycle carries a steeper value drop and a used device that is one generation back can be a strong value if the treatments it delivers still command full pricing. Either way, the financing should reflect the real curve of the specific device.

Revenue Per Treatment as the Underwriting Driver

More than almost any other medical category, aesthetic equipment is bought to generate revenue per treatment and that revenue is the real driver of the underwriting. An RF microneedling session commonly prices in the several-hundred to roughly two-thousand-dollar range and body-contouring packages often run well into the low thousands, so a single device can pay for itself through patient throughput. Because of that, financing an aesthetic device is closer to underwriting a practice than a bare asset. A lender in this category weighs the treatments the device can deliver, the pricing in the local market and the expected patient volume alongside the borrower profile. This matters especially for the many aesthetic buyers who are new practices or single-location med-spas with a thin operating history, because a realistic equipment cash-flow picture can carry more weight than a long balance sheet. The practical version of this for an owner is simple: know what the target treatment sells for in the local market, know roughly how many sessions the device can support in a week and be ready to speak to how the new service fits the existing patient base. A device that adds a high-margin treatment to a practice that already has patient flow tells a stronger story than the same device dropped into a location with no established demand and a lender who understands aesthetics will listen for exactly that difference when sizing the structure.

What Lenders Evaluate on Aesthetic Equipment

Across every device type, a few factors carry outsized weight. The secondary-market value of the specific unit is central, because the resale market sets the collateral value, not the invoice. The technology generation and model year matter, since a superseded device can lose value quickly. Consumables, handpiece licensing and per-treatment or per-cycle fees are important, because they tie the asset to an ongoing manufacturer payment stream and change how the device behaves as standalone collateral. The revenue the device can produce, expressed as treatment pricing and expected throughput, is weighed alongside the owner profile, especially for newer practices. Finally, a documented, serviceable device with its handpieces, service records and any transferable warranty supports better terms than an unit of unknown history. The more clearly the device and its economics are documented, the smoother the financing.

Getting Started

Start your application at ileasecapital.com/apply, it takes about three minutes and there is no hard credit pull. The most useful details to have ready are the device type and configuration, whether the system is new, used or refurbished, the model year and any handpieces or modules, the consumable or per-treatment cost structure, the vendor or dealer and the purchase price. Smaller aesthetic purchases may qualify for application-only financing, while larger platforms and body-contouring systems are typically structured with additional documentation and several devices can be presented together as one build-out.

Financing Aesthetic Equipment Through iLease Capital

iLease Capital works with med-spas, dermatology and plastic surgery practices and cosmetic clinics acquiring new, used and refurbished aesthetic equipment across every device type. As a broker with more than 50 lender relationships, iLease can match a specific device to a funding partner that understands the active secondary market and the fast depreciation curve of aesthetic collateral and financing may be available for transactions up to $5 million plus. Whether you are financing a standalone IPL system, a premium laser platform, a body-contouring system or a full build-out of several devices, send the device list and pricing, or call us at (866) 545-3273. For the full range of clinical categories, see our medical equipment financing hub.

Frequently asked questions